Jump to main content
Jump to site search

Issue 1, 2021
Previous Article Next Article

Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy

Author affiliations

Abstract

Compared to traditional drug delivery systems, DNA nanostructure-based drug delivery systems have several advantages including programmable sequences, precise size and shape, high drug payloads, excellent biocompatibility and biodegradability. To date, a wide range of chemotherapeutic drug–DNA hybrid nanostructures have been developed for anti-tumor therapy. In this review, the constructions of various DNA nanostructures for anticancer drug delivery are firstly summarized. Next, the anticancer drug loading methods for DNA nanostructures are presented. Then, the recent applications of chemotherapeutic drug–DNA hybrid nanostructures for drug delivery are highlighted. In the end, the challenges and opportunities of the chemotherapeutic drug–DNA hybrid nanostructure-based delivery system are discussed. The designs of drug–DNA hybrid systems, including the constructions of nanostructures and the strategies for drug loading, largely influence the efficiency of drug delivery. Recent studies have focused on the development of novel drug–DNA hybrid systems to acquire more precise and efficient therapy for various diseases. A systematic review of the design strategies of chemotherapeutic drug–DNA hybrid nanostructures will benefit the innovation and development of the chemotherapeutic drug-based chemotherapy in clinics.

Graphical abstract: Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy

Back to tab navigation

Article information


Submitted
30 Ապր 2020
Accepted
18 Օգս 2020
First published
19 Օգս 2020

Mater. Horiz., 2021,8, 78-101
Article type
Review Article

Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy

X. Huang, N. T. Blum, J. Lin, J. Shi, C. Zhang and P. Huang, Mater. Horiz., 2021, 8, 78
DOI: 10.1039/D0MH00715C

Social activity

Search articles by author

Spotlight

Advertisements